These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37189724)
21. Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review. Bruno G; Buccoliero GB Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895350 [TBL] [Abstract][Full Text] [Related]
22. Oral Brincidofovir Therapy for Monkeypox Outbreak: A Focused Review on the Therapeutic Potential, Clinical Studies, Patent Literature, and Prospects. Imran M; Alshammari MK; Arora MK; Dubey AK; Das SS; Kamal M; Alqahtani ASA; Sahloly MAY; Alshammari AH; Alhomam HM; Mahzari AM; Abida ; Rabaan AA; Dzinamarira T Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830816 [TBL] [Abstract][Full Text] [Related]
23. Ocular manifestations of mpox. Nguyen M; Doan T; Seitzman GD Curr Opin Ophthalmol; 2024 Jun; ():. PubMed ID: 38847744 [TBL] [Abstract][Full Text] [Related]
24. Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection. Fortier JC; Marsalisi C; Cordova E; Guo HJ; Verdecia J Open Forum Infect Dis; 2024 Apr; 11(4):ofae138. PubMed ID: 38651138 [TBL] [Abstract][Full Text] [Related]
25. Characterization of interventional clinical trials for monkeypox; systematic review of ClinicalTrials.gov database. Alorfi NM; Alshehri FS; Haseeb A Front Public Health; 2023; 11():1144325. PubMed ID: 36969617 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of tecovirimat in subjects with Mpox. Tempestilli M; Mondi A; D'Avolio A; Forini O; Pinnetti C; Mazzotta V; Gagliardini R; Beccacece A; De Nicolò A; Faccendini P; Cimini E; Maggi F; Girardi E; Nicastri E; Boffito M; Vaia F; Antinori A Int J Antimicrob Agents; 2024 Feb; 63(2):107068. PubMed ID: 38141836 [TBL] [Abstract][Full Text] [Related]
27. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks. Islam MR; Hossain MJ; Roy A; Hasan AHMN; Rahman MA; Shahriar M; Bhuiyan MA Health Sci Rep; 2022 Sep; 5(5):e798. PubMed ID: 36032515 [TBL] [Abstract][Full Text] [Related]
29. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach. Sahu A; Gaur M; Mahanandia NC; Subudhi E; Swain RP; Subudhi BB Comput Biol Med; 2023 Jul; 161():106971. PubMed ID: 37211001 [TBL] [Abstract][Full Text] [Related]
30. The global patent landscape of emerging infectious disease monkeypox. Cai Y; Zhang X; Zhang K; Liang J; Wang P; Cong J; Xu X; Li M; Liu K; Wei B BMC Infect Dis; 2024 Apr; 24(1):403. PubMed ID: 38622539 [TBL] [Abstract][Full Text] [Related]
31. Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study. Tomita N; Morino E; Terada-Hirashima J; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Ebihara H; Shimojima M; Sugiura W; Ohmagari N; Ujiie M Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983942 [TBL] [Abstract][Full Text] [Related]
32. Monkeypox and drug repurposing: seven potential antivirals to combat the viral disease. Varghese R; Patel P; Kumar D; Sharma R Rev Environ Health; 2023 Feb; ():. PubMed ID: 36809250 [TBL] [Abstract][Full Text] [Related]
39. Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System. Vo C; Zomorodi R; Silvera R; Bartram L; Lugo LA; Kojic E; Urbina A; Aberg J; Sigel K; Chasan R; Patel G Open Forum Infect Dis; 2023 Nov; 10(11):ofad552. PubMed ID: 38023539 [TBL] [Abstract][Full Text] [Related]
40. Application of Artificial Intelligence Techniques for Monkeypox: A Systematic Review. Chadaga K; Prabhu S; Sampathila N; Nireshwalya S; Katta SS; Tan RS; Acharya UR Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36899968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]